Crossmark

Effectiveness and safety in the management of chronic inflammatory diseases with etanercept and infliximab biosimilars in Colombian patients

Crossref DOI link: https://doi.org/10.1016/j.rcreue.2021.05.002

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Machado-Duque, Manuel Enrique

Gaviria-Mendoza, Andrés

Toro-Jiménez, Juan Camilo

Cano-Marín, Santiago

Osorio-Gutiérrez, Lorena

Hernández-Cano, Luis Felipe

Machado-Alba, Jorge Enrique
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and safety in the management of chronic inflammatory diseases with etanercept and infliximab biosimilars in Colombian patients

Journal Title: Revista Colombiana de Reumatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rcreue.2021.05.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rcreu.2021.05.013

Content Type: article

Copyright: © 2021 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved.